Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which bowel care tool wins the race? trial pits suppository, enema, and irrigation device

NCT ID NCT07817199

Symptom relief Sponsor: Casa Colina Hospital and Centers for Healthcare Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 14, 2026 · Last updated Sep 15, 2026 · Updated 1 time

Summary

People with spinal cord injuries often rely on a bowel program to manage neurogenic bowel, a condition that makes it hard to control bowel movements. This trial compares three tools used during those programs: a bisacodyl suppository, a mini enema called Enemeez, and a transanal irrigation device called Peristeen. Researchers want to see which tool helps participants finish their bowel program in the least amount of time and whether it reduces episodes of incontinence or constipation. About 30 patients admitted to an inpatient rehab unit will use one of the tools and answer questions about their experience.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a bisacodyl suppository, a mini enema, or a transanal irrigation device
What this could lead to
If one tool proves faster and more reliable, rehab centers could adopt it as a standard approach, cutting the time patients spend on bowel care and improving their daily comfort.
What could go wrong
This is a small study of 30 people at a single hospital, so the results may not apply to everyone with spinal cord injury. Each tool also carries its own risks, such as irritation or autonomic dysreflexia, and no single option may clearly win.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * admission to acute rehab inpatient unit * diagnosis of spinal cord injury * reflexive type neurogenic bowel requiring bowel program with suppository and digital stimulation Exclusion Criteria: * anal or rectal stenosis * active inflammatory bowel disease * acute diverticulitis * colorectal cancer * ischemic colitis * rectal surgery within the last 3 months * endoscopic polypectomy within the last 4 weeks * areflexic bowel * severe autonomic dysreflexia

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neurogenic bowel are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neurogenic bowel spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neurogenic bowel Spinal cord injury

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.